Abstract
Pan-aminoglycoside (amikacin, gentamicin, tobramycin, plazomicin)-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates from patients in Canadian Hospitals (2013-2017) were evaluated by whole genome sequencing for 16S ribosomal RNA methyltransferase genes. The rmtB gene was detected in 2 isolates (1 of 3094 E. coli [0.03%], 1 of 1039 K. pneumoniae [0.1%]).
Keywords:
16S rRNA methyltransferase; Aminoglycoside; Antimicrobial resistance; Gram-negative; Plazomicin; rmtB.
Copyright © 2018 Elsevier Inc. All rights reserved.
MeSH terms
-
Aminoglycosides / pharmacology
-
Anti-Bacterial Agents / pharmacology
-
Canada / epidemiology
-
Drug Resistance, Multiple, Bacterial
-
Escherichia coli / enzymology*
-
Escherichia coli / genetics
-
Escherichia coli / isolation & purification
-
Escherichia coli Infections / epidemiology
-
Escherichia coli Infections / microbiology*
-
Hospitals
-
Humans
-
Klebsiella Infections / epidemiology
-
Klebsiella Infections / microbiology*
-
Klebsiella pneumoniae / drug effects
-
Klebsiella pneumoniae / enzymology*
-
Klebsiella pneumoniae / genetics
-
Klebsiella pneumoniae / isolation & purification
-
Methyltransferases / genetics*
-
Methyltransferases / metabolism
-
RNA, Ribosomal, 16S / metabolism*
-
Sequence Analysis, DNA
-
Whole Genome Sequencing
Substances
-
Aminoglycosides
-
Anti-Bacterial Agents
-
RNA, Ribosomal, 16S
-
Methyltransferases
-
rRNA (adenosine-O-2'-)methyltransferase